L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease

Neuropsychopharmacology

Volumn 32, Issue 1, 2007, Pages 180-189

  Cools, Roshan ^a,c   Lewis, Simon J G ^a   Clark, Luke ^a   Barker, Roger A ^b   Robbins, Trevor W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UK   (United Kingdom)

Author keywords

Accumbens; Cognition; Dopamine; fMRI; Learning; Parkinson's disease

Indexed keywords

LEVODOPA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LEARNING; MALE; NERVE CELL; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; TASK PERFORMANCE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NUCLEUS ACCUMBENS; OXYGEN; PARKINSON DISEASE; PREFRONTAL CORTEX; REVERSAL LEARNING;

EID: 33845696933     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301153     Document Type: Article

References (58)

1. Annett L, McGregor A, Robbins T (1989). The effects of ibutenic acid lesions of the nucleus accumbens on spatial learning and extinction in the rat. Behav Brain Res 31: 231-242.
2. Arnsten AFT (1998). Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 2: 436-446.
3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatr 11: 561-571.
4. Brett M, Anton J-L, Valabregue R, Poline J-B (2002). Region of interest analysis using an SPM toolbox. NeuroImage 16: 2 (abstract).
5. Carelli R (2004). Nucleus accumbens cell firing and rapid dopamine signaling during goal-directed behaviors in rats. Neuropharmacology 47: 180-189.
6. Carey R, Dai H, Huston J, Pinheiro-Carrera M, Schwarting R, Tomaz C (1995). L-DOPA metabolism in cortical and striatal tissues in an animal model of parkinsonism. Brain Res Bull 37: 295-299.
7. Cools AR (1980). Role of the neostriatal dopaminergic activity in sequencing and selecting behavioural strategies: facilitation of processes involved in selecting the best strategy in a stressful situation. Behav Brain Res 1: 361-378.
8. Cools R, Clark L, Robbins T (2004). Differential responses in human striatum and prefrontal cortex to changes in object and rule relevance. J Neurosci 24: 1129-1135.
9. Cools R, Barker RA, Sahakian BJ, Robbins TW (2001). Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 11: 1136-1143.
10. Cools R, Clark L, Owen AM, Robbins TW (2002a). Defining the neural mechanisms of probabilistic reversal learning using event-related functional Magnetic Resonance Imaging. J Neurosci 22: 4563-4567.
11. Cools R, Barker RA, Sahakian BJ, Robbins TW (2003). L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 41: 1431-1441.
12. Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM (2002b). Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125: 584-594.
13. Crofts HS, Dalley JW, Van Denderen JCM, Everitt BJ, Robbins TW, Roberts AC (2001). Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cereb Cortex 11: 1015-1026.
14. Cusack R, Papadakis N (2002). New robust 3-d phase unwrapping algorithms: application to magnetic field mapping and undistorting echoplanar images. NeuroImage 16: 754-764.
15. Dagher A, Owen AM, Boecker H, Brooks DJ (2001). The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease. Brain 124: 1020-1032.
16. Divac I, Rosvold HE, Szwarcbart MK (1967). Behavioral effects of selective ablation of the caudate nucleus. J Comp Physiol Psychol 63: 184-190.
17. Evers E, Cools R, Clark L, van der Veen F, Jolles J, Sahakian B et al (2005). Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology 30: 1138-1147.
18. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987). Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Caine D, Goldstein M (eds). Recent developments in Parkinson's disease. McMillan Health Care Information: Florham Park, NJ.
19. Farley I, Price K, Hornykiewicz O (1977). Dopamine in the limbic regions of the human brain: normal and abnormal. Adv Biochem Psychopharmacol 16: 57-64.
20. Folstein MF, Folstein SE, McHugh PR (1975). 'Mini Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
21. Frank M, Seeberger L, O'Reilly R (2004). By carrot and stick: cognitive reinforcement learning in parkinsonism. Science 306: 1940-1943.
22. Goldman-Rakic P (1992). Dopamine-mediated mechanisms of the prefrontal cortex. Semin Neurosci 4: 109-118.
23. Gotham AM, Brown RG, Marsden CD (1988). 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 111: 299-321.
24. Goto Y, Grace A (2005). Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci 8: 805-812.
25. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins T (2000). Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20: 1208-1215.
26. Hoehn MM, Yahr MD (1967). Parkinsonism: onset, progression and mortality. Neurology 17: 427-442.
27. Hollerman JR, Schultz W (1998). Dopamine neurons report an error in the temporal prediction of reward during learning. Nat Neurosci 1: 304-309.
28. Hornykiewicz O (1974). The mechanisms of action of L-DOPA in Parkinson's disease. Life Sci 15: 1249-1259.
29. Kish SJ, Shannak K, Hornykiewicz O (1988). Uneven patterns of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. New Engl J Med 318: 876-880.
30. Knutson B, Adams CM, Fong G, Hommer D (2001). Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 21: 1-5.
31. Knutson B, Taylor J, Kaufman M, Peterson R, Glover G (2005). Distributed neural representation of expected value. J Neurosci 25: 4806-4812.
32. Lewis S, Dove A, Robbins T, Barker R, Owen A (2003). Cognitive impairments in early parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 23: 6351-6356.
33. Lewis S, Dove A, Robbins T, Barker R, Owen A (2004). Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 19: 755-760.
34. 158Met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186-6191.
35. Mattay VS, Tessitore A, Callicott JH, Bertonlino A, Goldberg TE, Chase TN et al (2002). Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 58: 630-635.
36. Mehta M, Manes F, Magnolfi G, Sahakian B, Robbins TW (2004). Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology 176: 331-342.
37. Mehta MA, Swainson R, Ogilvie AD, Sahakian BJ, Robbins TW (2001). Improved short-term spatial memory but impaired reversal learning following the dopamine D2 agonist bromocriptine in human volunteers. Psychopharmacology 159: 10-20.
38. Meyer-Lindenberg A, Kohn P, Kolachana B, Kippenhan S, McInerney-Leo A, Nussbaum R et al (2005). Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 8: 594-596.
39. Mogenson G (1987). Limbic-Motor Integration. Prog Psychobiol Physiol Psychol 12: 117-169.
40. Monchi I, Petrides M, Doyon J, Postuma R, Worsley K, Dagher A (2004). Neural bases of set-shifting deficits in Parkinson's disease. J Neurosci 24: 702-710.
41. Owen AM, Doyon J, Dagher A, Sadikot A, Evans AC (1998). Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 121: 949-965.
42. Owen AM, James M, Leigh JM, Summers BA, Marsden CD, Quinn NP et al (1992). Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115: 1727-1751.
43. Parkinson J, Olmstead M, Burns L, Robbins TW, Everitt B (1999). Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. J Neurosci 19: 2401-2411.
44. Phillips A, Ahn S, Floresco S (2004). Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. J Neurosci 14: 547-553.
45. Redgrave P, Prescott TJ, Gurney K (1999). The basal ganglia: a vertebrate solution to the selection problem? Neuroscience 89: 1009-1023.
46. Robbins TW (2000). Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp Brain Res 133: 130-138.
47. Robbins TW, Cador M, Taylor JR, Everitt BJ (1989). Limbic-striatal interactions in reward-related processes. Neurosci Biobehav Rev 13: 155-162.
48. Schoenbaum G, Setlow B (2003). Lesions of nucleus accumbens disrupt learning about aversive outcomes. J Neurosci 23: 9833-9841.
49. Schultz W (2002). Getting formal with dopamine and reward. Neuron 36: 241-263.
50. Smith A, Neill J, Costall B (1999). The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset. Pharmacol Biochem Behav 63: 201-211.
51. Smith S (2002). Fast robust automated brain extraction. Human Brain Mapping 17: 143-155.
52. Stern C, Passingham R (1995). The nucleus accumbens in monkeys (Macaca fascicularis). Exp Brain Res 106: 239-247.
53. Swainson R, Rogers RD, Sahakian BJ, Summers BA, Polkey CE, Robbins TW (2000). Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 38: 596-612.
54. Taghzouti K, Louilot A, Herman J, Le Moal M, Simon H (1985). Alternation behaviour, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the rat. Behav Neural Biol 44: 354-363.
55. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N et al (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15: 273-289.
56. Wilson D, Bowman E (2005). Rat nucleus accumbens neurons predominantly respond to the outcome-related properties of conditioned stimuli rather than their behavioral-switching properties. J Neurophysiol 94: 49-61.
57. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC (1996). A unified statistical approach for determining significant signals in images of cerebral activation. Human Brain Mapping 4: 58-73.
58. Zahrt J, Taylor JR, Mathew RG, Arnsten AFT (1997). Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17: 8528-8535.